BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 1725623)

  • 1. [Comparative evaluation of 3 leukocyte filters for thrombocyte concentrates].
    Reiser M; Kádár JG; Borberg H
    Beitr Infusionsther; 1991; 28():216-9. PubMed ID: 1725623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of leukocyte depleting polyester filters on thrombocytapheresis concentrates].
    Weisbach V; Riess H; Gindi N; Serke S; Zeiler T; Riewald M; Zingsem J; Eckstein R
    Beitr Infusionsther; 1992; 30():170-3. PubMed ID: 1284699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of four filters for leukocyte depletion of single donor plateletapheresis products.
    Sintnicolaas K; van Putten WL
    Transfus Sci; 1993 Apr; 14(2):211-5. PubMed ID: 10148614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White blood cell-reduced platelet concentrates prepared by filtration using the Sepacell PL 5 II/10 II filter.
    Müller N; Knop D
    Beitr Infusionsther Transfusionsmed; 1994; 32():58-60. PubMed ID: 9422102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providing leukocyte-reduced platelets using the CS-3000 PLUS.
    Abreu ED; Strauss RG; Cordle DG; Kingery LR; Ludwig GA; Randels MJ
    J Clin Apher; 1996; 11(1):27-9. PubMed ID: 8722719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in thrombocytapheresis concentrations caused by leukocyte depletion with polyester filters].
    Weisbach V; Riess H; Gindi N; Zeiler T; Riewald M; Zingsem J; Eckstein R
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):146-8. PubMed ID: 1498557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Procedure for production of leukocyte depleted erythrocyte and thrombocyte concentrates (PRP method) using top and bottom bags, Optipress automated separators and a computer controlled Cryofuge 6000].
    Aulmann M; Ullrich R; Iber B; Neppert J
    Beitr Infusionsther; 1992; 30():122-6. PubMed ID: 1284686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production of leukocyte-poor thrombocyte concentrates: results with a new kind of filter system].
    Böck M; Salat C; Greither L; Heim MU; Weindler R; Bilas A; Mempel W
    Beitr Infusionsther; 1990; 26():103-5. PubMed ID: 1703804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In-line leukocyte depletion ov thrombocytapheresis concentrates with the Fresenius-AS-104 cell separator].
    Zeiler T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1997; 34():110-3. PubMed ID: 9417333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
    Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
    Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of platelet and leukocyte content in platelet concentrates obtained from CS-3000 and third generation (CS-3000 plus and Cobe-Spectra) cell separators].
    Dzieciatkowska A; Fuksiewicz M; Lachert E; Ziemba-Zółtowska B; Letowska M
    Acta Haematol Pol; 1995; 26(3):285-9. PubMed ID: 8525774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.
    Riggert J; Humpe A; Simson G; Köhler M
    Vox Sang; 1998; 74(3):182-8. PubMed ID: 9595646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a platelet apheresis technique for the preparation of leukocyte-reduced platelet concentrates.
    Zingsem J; Glaser A; Weisbach V; Zimmermann R; Neidhardt B; van Waeg G; Eckstein R
    Vox Sang; 1998; 74(3):189-92. PubMed ID: 9595647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte-depleted platelets prepared from pooled buffy coat post-transfusion increment and "in vitro bleeding time" using the Thrombostat 4000/2.
    Högman CF; Eriksson L; Kristensen J
    Transfus Sci; 1993 Jan; 14(1):35-9. PubMed ID: 10148311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma].
    Zeiler T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of plateletpheresis systems].
    Kretschmer V
    Beitr Infusionsther; 1991; 28():162-76. PubMed ID: 1725615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leuko-reduction using an integral Sepacell filter early (4 h, 24 h) or late (48 h, 120 h) after plateletpheresis does not affect platelet function.
    Müller TH; Schmidt S; Döscher A; Weiss H; Schunter F
    Beitr Infusionsther Transfusionsmed; 1997; 34():95-9. PubMed ID: 9356661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of thrombocyte concentrates of the cell separator AS 104 with preparations of the cell separator CS 3000 (Fenwal)].
    Aulmann HM; Müller R; Zaky M; Avenarius HJ; Stangel W
    Beitr Infusionsther; 1990; 26():127-30. PubMed ID: 1703811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimizing cell separation with the Cell Separator AS-106].
    Kretschmer V; Rossa C
    Beitr Infusionsther; 1991; 28():188-94. PubMed ID: 1725617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.